An antigenic peptide produced by peptide splicing in the proteasome.
about
Four independent mutations in the feline fibroblast growth factor 5 gene determine the long-haired phenotype in domestic catsDatabase of T cell-defined human tumor antigens: the 2013 updateInvestigation of Serine-Proteinase-Catalyzed Peptide Splicing in Analogues of Sunflower Trypsin Inhibitor 1 (SFTI-1)DNA vaccine for cancer immunotherapyThe Human Immunopeptidome Project, a suggestion for yet another postgenome next big thingComputational prediction of cleavage using proteasomal in vitro digestion and MHC I ligand data.Protein splicing and auto-cleavage of bacterial intein-like domains lacking a C'-flanking nucleophilic residue.Proteomics in cancer vaccine development.EpiJen: a server for multistep T cell epitope prediction.Proteasomal processing of albumin by renal dendritic cells generates antigenic peptides.The 20S proteasome splicing activity discovered by SpliceMet.Pathways of antigen processing.Attraction and activation of dendritic cells at the site of tumor elicits potent antitumor immunity.ESAT-6/CFP-10 fusion protein and peptides for optimal diagnosis of mycobacterium tuberculosis infection by ex vivo enzyme-linked immunospot assay in the GambiaModelling proteasome and proteasome regulator activities.Concurrent detection of circulating minor histocompatibility antigen-specific CD8+ T cells in SCT recipients by combinatorial encoding MHC multimersToward Understanding the Essence of Post-Translational Modifications for the Mycobacterium tuberculosis ImmunoproteomeTargeting the intratumoral dendritic cells by the oncolytic adenoviral vaccine expressing RANTES elicits potent antitumor immunityAn antigenic peptide produced by reverse splicing and double asparagine deamidationDriving forces of proteasome-catalyzed peptide splicing in yeast and humans.Integrated modeling of the major events in the MHC class I antigen processing pathway.Enzymatic amine acyl exchange in peptides on gold surfaces.Protein multifunctionality: principles and mechanisms.An antigen produced by splicing of noncontiguous peptides in the reverse order.Investigation of peptide splicing using two-peptide-chain analogs of trypsin inhibitor SFTI-1.Definition of Proteasomal Peptide Splicing Rules for High-Efficiency Spliced Peptide Presentation by MHC Class I MoleculesMHC-bound antigens and proteomics for novel target discovery.Quantitative time-resolved analysis reveals intricate, differential regulation of standard- and immuno-proteasomesN-terminal additions to the WE14 peptide of chromogranin A create strong autoantigen agonists in type 1 diabetesAntigen-specific cellular immunotherapy of leukemia.Complexity, contradictions, and conundrums: studying post-proteasomal proteolysis in HLA class I antigen presentation.The T210M Substitution in the HLA-a*02:01 gp100 Epitope Strongly Affects Overall Proteasomal Cleavage Site Usage and Antigen Processing.Proteomic contributions to our understanding of vaccine and immune responses.Reverse immunology approach for the identification of CD8 T-cell-defined antigens: advantages and hurdles.Contribution of mass spectrometry-based proteomics to immunology.Proteasomes generate spliced epitopes by two different mechanisms and as efficiently as non-spliced epitopesVaccination with the recombinant major outer membrane protein elicits antibodies to the constant domains and induces cross-serovar protection against intranasal challenge with Chlamydia trachomatis.Identification of T-cell epitopes for cancer immunotherapy.Diversity of proteasomal missions: fine tuning of the immune response.Pathogenic CD4 T cells in type 1 diabetes recognize epitopes formed by peptide fusion
P2860
Q24629608-EEE79002-3CC6-4395-8119-260E53D334A2Q27022422-00F2179D-8C25-4ABC-A310-D7560DDC6269Q27701655-F4C765E3-B692-4D66-90D1-19C028B47126Q28080919-6B18E19E-6C45-459F-8016-85F81F671585Q28743282-A04045D3-C2F8-4EEC-BAC6-F10F6B046456Q30665275-729B6906-447B-40B2-9569-BF3A9097705AQ33203024-A8B96785-BB70-4231-8D8F-6ED13DC14B42Q33215044-26A10141-31A4-4BC3-8633-EBC5E2CA1A18Q33236277-6C8EBD66-19A7-45BC-A94B-EEA1766A3214Q33394150-61C8DB72-7A60-4AA5-A8B7-086C3BA3666EQ33627497-2F65CE6C-4291-4D3D-B985-81EADA304F39Q33631854-1C51B303-954C-41AA-ADBA-D1F4B1E1822FQ33713956-1D571F61-C359-47BD-82CE-40EFC4384664Q33859249-85C6F1A0-FF31-4E50-9368-54019FBF1D90Q33912642-79274F07-E711-4480-B9E9-62AE30506B4FQ33952256-3FB8688A-2B20-4AE1-9672-7A68434D12B3Q34024201-16A5930F-EB15-44F1-9560-316E9E661C3EQ34096503-FFB4E81B-3786-46BC-ABC8-9D1715B194AEQ34192290-569E4E17-1ECC-49CF-98AD-3F633D49EED5Q34347732-045D0385-B0E9-4767-87AE-AB1C768E4822Q34429970-5A32DA8D-6CEB-4E04-8E04-B77E38072EC2Q34481736-456CC7A9-C070-4579-8394-4F2355E50B98Q34497721-2C3579D5-F518-4263-9476-FC641DAC8746Q34564542-4119788F-D9B2-43D4-B4E3-1FA2A0221036Q35013513-30879F08-DF49-455F-902D-B09095ECC4CBQ35786206-4724F42D-D088-47ED-B232-64A1C44A25FBQ35911151-CC549D67-97F9-472A-A097-303EA4370B20Q36177598-F1A05FF6-D237-4F1E-B601-2A252DDCE0D0Q36238365-16FC0F25-70F0-45B8-8F91-5FFF46713207Q36240201-A9E6E56E-D0AA-4C12-BBF3-D5F4DC710E82Q36266433-1FCA0581-804B-4E36-8D3D-2DD433A93607Q36381923-A68A2D78-9DAE-4707-B3EF-D26423C01A7FQ36464016-5FE82529-8B0A-4F9C-AC56-C77D5A67E8F7Q36471831-862693F9-DBBE-4D5F-B4FC-DD9EE52EE8A9Q36689114-D6A7BA29-52EE-43B2-8D8F-52CBA57D01FAQ36769053-A0BBBAB6-955A-4506-BF7B-EBDD43A8F9D6Q36827004-64DBFC08-682D-4E01-B736-0AD591690498Q36870592-A168B7E8-8185-4E00-B6AB-B05B2242FD31Q36909248-A387D49F-3200-4C27-8342-6EF4FDE93B38Q36945852-BFDB0D43-4C66-4264-9E80-4B93255A41F9
P2860
An antigenic peptide produced by peptide splicing in the proteasome.
description
2004 nî lūn-bûn
@nan
2004 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի մարտին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
An antigenic peptide produced by peptide splicing in the proteasome.
@ast
An antigenic peptide produced by peptide splicing in the proteasome.
@en
An antigenic peptide produced by peptide splicing in the proteasome.
@nl
type
label
An antigenic peptide produced by peptide splicing in the proteasome.
@ast
An antigenic peptide produced by peptide splicing in the proteasome.
@en
An antigenic peptide produced by peptide splicing in the proteasome.
@nl
prefLabel
An antigenic peptide produced by peptide splicing in the proteasome.
@ast
An antigenic peptide produced by peptide splicing in the proteasome.
@en
An antigenic peptide produced by peptide splicing in the proteasome.
@nl
P2093
P356
P1433
P1476
An antigenic peptide produced by peptide splicing in the proteasome.
@en
P2093
Annie Ooms
Benoît J Van den Eynde
Gérard Degiovanni
Jacques Chapiro
Nathalie Vigneron
Pierre van der Bruggen
Sandra Morel
Thierry Boon
Vincent Stroobant
P304
P356
10.1126/SCIENCE.1095522
P407
P577
2004-03-04T00:00:00Z